Britta Höchsmann - Concepedia

Author

Britta Höchsmann

Also Known As

B Höchsmann, B. Höchsmann, B. Höchsmann, Britta Hochsmann, Britta Höchsmann, Britta Höchsmann, Hochsmann, Britta, Höchsmann, Britta

107

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Universität Ulm German Red Cross University Hospital Ulm Hôpital Saint-Louis RWTH Aachen University

About

Britta Höchsmann is an author at Universität Ulm specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	542
2	Natural Sciences	3	3	64
3	Health Sciences	2	2	67
4	Engineering	1	1	68
5	Biochemistry	1	1	15

Britta Höchsmann

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Peter Hillmen, Jeff Szer, Ilene C. Weitz, New England Journal of Medicine	2021	356
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria Richard J. Kelly, Britta Höchsmann, Jeff Szer, New England Journal of Medicine	2015	264
A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation André Tichelli, Hubert Schrezenmeier, Gèrard Socié, Blood	2011	208
Similar outcome of upfront‐unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the <scp>UK</scp> Paediatric <scp>BMT</scp> Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of <scp>EBMT</scp> Carlo Dufour, Paul Veys, Elisa Carraro, British Journal of Haematology TransplantationMarrow TransplantationKidney TransplantSimilar OutcomePediatric Hematology	2015	174
Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood–derived platelets and apheresis platelets Hubert Schrezenmeier, Gabriele Walther‐Wenke, Thomas Müller, Transfusion	2007	165
Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation Markus J. Harder, Nadine Kuhn, Hubert Schrezenmeier, Blood	2016	136
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria Régis Peffault de Latour, Alexander Röth, Austin Kulasekararaj, New England Journal of Medicine	2024	119
A case of paroxysmal nocturnal hemoglobinuria caused by a germline mutation and a somatic mutation in PIGT Peter Krawitz, Britta Höchsmann, Yoshiko Murakami, Blood	2013	91
Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity Marco Mannes, Arthur Dopler, Oliver Zolk, Blood	2020	89
Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload Florian Nolte, Britta Höchsmann, Aristoteles Giagounidis, Annals of Hematology Hematological MalignancyBone Marrow FailureOral DeferasiroxSingle ArmMulti-center Trial	2012	77

Page 1